Postscript stock

Private-market facts for current and former Postscript employees researching their stock.

Latest Round
Series C
Valuation
Not publicly disclosed
Founded
2018
Headquarters
Scottsdale, AZ
Founders
Adam Turner, Alex Beller
Status
private
Employees
293 -14% YoY
Total Raised
$167M

Talk to a Postscript stock specialist

Get personalized guidance on your Postscript shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Postscript is an SMS marketing platform for Shopify stores, enabling e-commerce brands to grow revenue through text message campaigns and automation.

Selling Postscript shares

Why shareholders consider selling

Shareholders in Postscript may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Postscript does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Postscript stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Enterprise Software sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Postscript shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Postscript shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Enterprise Software market conditions, and any recent private-market transaction activity. Data points such as the company's Series C round can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

Tools for Postscript shareholders

Exploring equity in Postscript often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Postscript most recently raised a Series C round . Total funding raised to date is approximately $167M.

Lead investors in this round include Y Combinator and Greylock Partners.

Postscript funding history

Pre Seed Round 2019
$2M
Seed Round 2019
$5M
Series B 2021
$35M
Series C 2022
$65M
Date Round Amount Lead investors
Jun 2022 Series C $65M 01 Advisors
Mar 2021 Series B $35M Greylock
Dec 2019 Seed Round $5M Accomplice
Mar 2019 Pre Seed Round $2M Y Combinator, 1984 Ventures

Postscript IPO & exit outlook

Postscript has not announced a confirmed IPO date or acquisition. At the Series C stage, most companies are still years away from a public listing or acquisition.

For employees holding equity, the timeline to liquidity is uncertain. Options to consider include:

Read our liquidity guide for a full comparison of paths to liquidity.

Founders & company background

Postscript was founded in 2018 by Adam Turner, Alex Beller and is headquartered in Scottsdale, AZ.

Investors

Industry

Similar private companies

Latest Postscript news

Talk to a Postscript stock specialist

Get personalized guidance on your Postscript shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Postscript a public or private company?
Postscript is a private company as of the most recent data available. Its shares do not trade on a public stock exchange. Employees and early shareholders who want liquidity may need to explore secondary-market options or wait for a future IPO or acquisition.
What is Postscript's valuation?
Postscript's valuation has not been publicly disclosed. Private company valuations are typically set during funding rounds and are not always reported publicly.
What is Postscript's stock price per share?
Postscript does not trade on a public exchange, so there is no single live stock price. Indicative pricing may be available through secondary-market platforms. The most recent known valuation data can help frame expectations, but common shares typically trade at a discount to the headline preferred-stock valuation.
When will Postscript IPO?
Postscript has not announced a confirmed IPO date. IPO timing depends on market conditions, company financials, and board decisions. Employees should plan around the possibility that liquidity may take years and consider whether secondary-market options or company-sponsored tender offers are available in the interim.
Can I sell my Postscript stock?
It depends on what you hold and your company's policies. Vested, exercised shares are generally eligible for secondary-market sales, subject to Postscript's transfer restrictions and right of first refusal (ROFR). Unexercised options and unvested RSUs typically cannot be sold. Some companies also run periodic tender offers that allow employees to sell a portion of their holdings at a set price. Check your equity agreement or speak with your stock plan administrator for Postscript-specific rules.
How much does it cost to exercise Postscript stock options?
The out-of-pocket cost equals your strike price multiplied by the number of shares you exercise. For ISOs, exercising may also trigger the Alternative Minimum Tax (AMT) based on the spread between your strike price and the current fair market value. For NSOs, the spread is taxed as ordinary income at exercise. Use our AMT Calculator and Stock Option Tax Calculator to model the cost for your specific situation.
What type of stock options does Postscript grant — ISOs or NSOs?
Most venture-backed companies grant ISOs (Incentive Stock Options) to U.S. employees where possible, with NSOs (Non-Qualified Stock Options) used for amounts exceeding the $100K annual ISO limit, for contractors, or for non-U.S. employees. Your specific grant type is listed in your option agreement. The distinction matters because ISOs can qualify for long-term capital gains treatment, while NSOs are taxed as ordinary income at exercise. See our ISO guide and NSO guide for the full breakdown.
What happens to my Postscript stock if the company is acquired?
In an acquisition, your equity outcome depends on the deal structure and your grant terms. Common scenarios include cash-out (your shares are bought at a set price per share), rollover (your shares convert into the acquirer's equity), or cancellation with an acceleration clause. If you have double-trigger acceleration, your unvested shares may accelerate only if you are also terminated. The liquidation preference stack determines how proceeds are divided — preferred shareholders are paid first, which can reduce or eliminate the payout to common shareholders in lower-value exits.
What is the difference between common and preferred Postscript stock?
Employees typically hold common stock (or options on common stock). Investors hold preferred stock, which usually comes with a liquidation preference — meaning investors get paid first in an exit before common shareholders receive anything. This distinction is critical when estimating what your shares might actually be worth in an exit.
What happens to my Postscript options if I leave?
When you leave a company, you typically have a limited post-termination exercise window — often 90 days — to exercise your vested options or they expire worthless. Some companies offer extended windows (up to 10 years). Unvested options are forfeited. If you hold ISOs and don't exercise within 90 days of leaving, they convert to NSOs, which changes the tax treatment. Review your option agreement for Postscript's specific terms, and use our Exercise Timing Planner to model the financial tradeoffs.

Related pages

Last verified: 2026-05-28 · Postscript data compiled from funding disclosures, investor announcements, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.